Literature DB >> 28574616

The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.

Afsane Bahrami1,2,3, Seyed Mahdi Hassanian2,4, Majid Khazaei5, Malihe Hasanzadeh6, Soodabeh Shahidsales7, Mina Maftouh2, Gordon A Ferns8, Amir Avan2,7.   

Abstract

The tumor microenvironment (TME) is cellular environment in addition to harboring carcinoma cells, consists of different components (e.g., blood vessels, immune cells, fibroblasts, bone marrow-derived inflammatory cells, lymphocytes, signaling molecules, and the extracellular matrix) that have an essential role on drug activity and efficacy. There is growing body of evidence showing its involvement in the progression and metastasis of different cancers, including breast cancer (BC). These observations provide a proof of concept of targeting TME compartments as a novel potential therapeutic approach in treatment of this malignancy, which is the main interested for current review. J. Cell. Biochem. 119: 111-122, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BREAST CANCER; FIBROBLAST; MACROPHAGE; SRTOMA; TUMOR MICROENVIRONMENT

Mesh:

Substances:

Year:  2017        PMID: 28574616     DOI: 10.1002/jcb.26183

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.

Authors:  Koushan Sineh Sepehr; Alireza Razavi; Zuhair Mohammad Hassan; Abdolreza Fazel; Meghdad Abdollahpour-Alitappeh; Majid Mossahebi-Mohammadi; Mir Saeed Yekaninejad; Behrouz Farhadihosseinabadi; Seyed Mahmoud Hashemi
Journal:  Cancer Immunol Immunother       Date:  2020-04-30       Impact factor: 6.968

Review 2.  Tumor microenvironment promotes breast cancer chemoresistance.

Authors:  Umar Mehraj; Abid Hamid Dar; Nissar A Wani; Manzoor A Mir
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-09       Impact factor: 3.333

3.  Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysis.

Authors:  Dalang Fang; Yanting Li; Yanghong Li; Yongcheng Chen; Qianfang Huang; Zhizhai Luo; Jinghua Chen; Yingjin Li; Zaizhi Wu; Yuanlu Huang; Yanfei Ma
Journal:  Gland Surg       Date:  2022-06

4.  3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells.

Authors:  Ju Hyun An; Woo Jin Song; Qiang Li; Dong Ha Bhang; Hwa Young Youn
Journal:  J Vet Sci       Date:  2021-03-05       Impact factor: 1.672

5.  Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.

Authors:  Qian Ye; Xiaowen Han; Zhengsheng Wu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 6.  Role of extracellular matrix in breast cancer development: a brief update.

Authors:  Manoj Kumar Jena; Jagadeesh Janjanam
Journal:  F1000Res       Date:  2018-03-05

Review 7.  The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis.

Authors:  Chia-Jung Li; Pei-Yi Chu; Giou-Teng Yiang; Meng-Yu Wu
Journal:  Biomolecules       Date:  2019-09-11

Review 8.  Pathological angiogenesis and inflammation in tissues.

Authors:  Ji-Hak Jeong; Uttam Ojha; You Mie Lee
Journal:  Arch Pharm Res       Date:  2020-11-23       Impact factor: 4.946

Review 9.  Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment.

Authors:  Jin Li; Diane J Burgess
Journal:  Acta Pharm Sin B       Date:  2020-05-31       Impact factor: 11.413

10.  The role of exosomal long non-coding RNAs in cancer drug resistance.

Authors:  Mireia Cruz De Los Santos; Mihnea P Dragomir; George A Calin
Journal:  Cancer Drug Resist       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.